ARM leads the conversation on policy and regulatory reform for CGT. As the sector’s collective voice, we work with governments, regulators, and payers to shape the future environment where transformative therapies reach patients faster, safely, and equitably.
ARM actively engages with global regulators to shape regulatory policy. We comment on draft guidance, participate in public meetings, and facilitate expert dialogue on complex issues like platform technologies.
ARM leads the agenda on policy and regulatory reform for cell & gene therapy. As the sector’s collective voice, we work with governments, regulators, and payers to shape a future where transformative therapies reach patients.
Through advisory groups, forums, and working groups, ARM engages diverse stakeholders to shape impactful, real-world policy.
Sign up for ARM’s weekly newsletter on sector news and alerts for events, reports, and other engagement opportunities.
